OMZIFY
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Oct 2025)
What this means for you
This application is over — abandoned 09 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90906209
- Mark type
- Stylized text
- Filed
- 27 Aug 2021
- Published for opposition
- 05 Jul 2022
- Abandoned
- 09 Oct 2025
- Attorney of record
- Kenneth F. Florek
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Handa Pharma, Inc., San Jose, CA, US
- Handa Pharma, Inc., San Jose, CA, US
Prosecution history
- 09 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 05 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2024 — SOU EXTENSION 4 GRANTED
- 05 Aug 2024 — SOU EXTENSION 4 FILED
- 05 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 01 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jan 2024 — SOU EXTENSION 3 GRANTED
- 30 Jan 2024 — SOU EXTENSION 3 FILED
- 30 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Aug 2023 — SOU EXTENSION 2 GRANTED
- 03 Aug 2023 — SOU EXTENSION 2 FILED
- 03 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 03 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED